CONGENITAL MUSCULAR DYSTROPHIES: P.329CALLISTO: a phase I open-label, sequential group, cohort study of pharmacokinetics and safety of omigapil in LAMA2 and COL6-related dystrophy patients. - Foley, A.R.; Leach, M.; Averion, G.; Hu, Y.; Yun, P.; Neuhaus, S.; Saade, D.; Arevalo, C.; Fink, M.; DeCoster, J.; Mendoza, C.; Mayer, O.; et al. (Neuromuscular Disorders, 2018)